FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Routes

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Physiology

Cytotoxicity, Immunologic

Disorders

Co-author Network

Publications

TOP 3
Nicole M Chase; Lawrence R Goodman; Mary K Hintermeyer; A Craig Mackinnon; Melodee L Nugent; R Nagarjun Rao; Kaushik S Shahir; Pippa M Simpson; Sumit Singh; William B Tisol; Aoy Tomita-Mitchell; James W Verbsky; Jill K Waukau; James T Casper; John Routes
Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
James W Verbsky; Monica Thakar; John Routes
The Wisconsin approach to newborn screening for severe combined immunodeficiency.
James W Verbsky; Christine M Seroogy; Mei W Baker; Benedetta Bonacci; Charles D Brokopp; James Casper; Trivikram Dasu; Ken Desantes; Miranda Gries; William J Grossman; Mary Hintermeyer; Gary L Hoffman; David Margolis; Sreelatha Reddy; John Routes
Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Routes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nicole M Chase; Lawrence R Goodman; Mary K Hintermeyer; A Craig Mackinnon; Melodee L Nugent; R Nagarjun Rao; Kaushik S Shahir; Pippa M Simpson; Sumit Singh; William B Tisol; Aoy Tomita-Mitchell; James W Verbsky; Jill K Waukau; James T Casper; John Routes
Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
Journal of clinical immunology 2013;33(1):30-9.
2012: James W Verbsky; Monica Thakar; John Routes
The Wisconsin approach to newborn screening for severe combined immunodeficiency.
The Journal of allergy and clinical immunology 2012;129(3):622-7.
2012: James W Verbsky; Christine M Seroogy; Mei W Baker; Benedetta Bonacci; Charles D Brokopp; James Casper; Trivikram Dasu; Ken Desantes; Miranda Gries; William J Grossman; Mary Hintermeyer; Gary L Hoffman; David Margolis; Sreelatha Reddy; John Routes
Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011).
Journal of clinical immunology 2012;32(1):82-8.
2011: Deborah J Accetta; Mei W Baker; Charles D Brokopp; James W Verbsky; John Routes
Cause of death in neonates with inconclusive or abnormal T-cell receptor excision circle assays on newborn screening.
Journal of clinical immunology 2011;31(6):962-7.
2011: Nicole M Chase; James W Verbsky; John Routes
Newborn screening for SCID: three years of experience.
Annals of the New York Academy of Sciences 2011;1238():99-105.
2011: Deborah J Accetta Pedersen; James W Verbsky; John Routes
Screening newborns for primary T-cell immunodeficiencies: consensus and controversy.
Expert review of clinical immunology 2011;7(6):761-8.
2011: Deborah Accetta; Grant Syverson; Benedetta Bonacci; Sreelatha Reddy; Christine Bengtson; Jill Surfus; Ronald Harbeck; Anna Huttenlocher; William Grossman; John Routes; James W Verbsky
Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia.
The Journal of allergy and clinical immunology 2011;127(2):535-538.e1-2.
2010: Nicole M Chase; James W Verbsky; John Routes
Newborn screening for T-cell deficiency.
Current opinion in allergy and clinical immunology 2010;10(6):521-5.
2010: Mei Wang Baker; Ronald H Laessig; Murray L Katcher; John Routes; William J Grossman; James Verbsky; Daniel F I Kurtycz; Charles D Brokopp
Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program.
Public health reports (Washington, D.C. : 1974) 2010;125 Suppl 2():88-95.
2009: John Routes; William J Grossman; James Verbsky; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Mei W Baker
Statewide newborn screening for severe T-cell lymphopenia.
JAMA : the journal of the American Medical Association 2009;302(22):2465-70.
2009: Mei W Baker; William J Grossman; Ronald H Laessig; Gary L Hoffman; Charles D Brokopp; Daniel F Kurtycz; Michael F Cogley; Thomas J Litsheim; Murray L Katcher; John Routes
Development of a routine newborn screening protocol for severe combined immunodeficiency.
The Journal of allergy and clinical immunology 2009;124(3):522-7.
2008: Jay R Radke; Zeba K Siddiqui; Tanya A Miura; John Routes; James L Cook
E1A oncogene enhancement of caspase-2-mediated mitochondrial injury sensitizes cells to macrophage nitric oxide-induced apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(12):8272-9.
2008: Yoshikazu Morimoto; John Routes
Immunodeficiency overview.
Primary care 2008;35(1):159-73, viii.
2007: Yoshikazu Morimoto; Edward D Chan; Leonid Heifets; John Routes
Pulmonary infection with Mycobacterium neoaurum identified by 16S ribosomal DNA sequence.
The Journal of infection 2007;54(4):e227-31.
2007: Tanya A Miura; James L Cook; Terence A Potter; Sharon Ryan; John Routes
The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
Journal of cellular biochemistry 2007;100(4):929-40.
2007: John Routes
Measurement of natural-killer cell lytic activity of adenovirus-infected or adenovirus-transformed cells.
Methods in molecular medicine 2007;131():213-9.
2005: John Routes; Sharon Ryan; Kristin Morris; Rayna Takaki; Adelheid Cerwenka; Lewis L Lanier
Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
The Journal of experimental medicine 2005;202(11):1477-82.
2005: Yoshikazu Morimoto; John Routes
Granulomatous disease in common variable immunodeficiency.
Current allergy and asthma reports 2005;5(5):370-5.
2005: Charlotte Cunningham-Rundles; John Routes; Robert Hostoffer; Kathleen E Sullivan
Uncommon conundrum in common variable immunodeficiency.
Clinical immunology (Orlando, Fla.) 2005;116(3):208-10.
2005: William H Wheat; Carlyne D Cool; Yoshikazu Morimoto; Pradeep R Rai; Charles H Kirkpatrick; Barbara A Lindenbaum; Christopher A Bates; Misoo C Ellison; Amanda E Serls; Kevin K Brown; John Routes
Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency.
The Journal of experimental medicine 2005;202(4):479-84.
2005: Francisco A Bonilla; I Leonard Bernstein; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Lisa J Kobrynski; Arnold I Levinson; Bruce Mazer; Robert P Nelson; Jordan S Orange; John Routes; William T Shearer; Ricardo U Sorensen
Practice parameter for the diagnosis and management of primary immunodeficiency.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;94(5 Suppl 1):S1-63.
2005: James L Cook; John Routes
Adenovirus E1A gene-induced tumor cell rejection through cellular sensitization to immune and nonimmune apoptotic injuries.
Frontiers in bioscience : a journal and virtual library 2005;10():1396-414.
2005: Daniel Ein; Rebecca S Gruchalla; James R Baker Jr; Joseph A Bellanti; Renata A M Engler; James F Jones; Bryan L Martin; John Routes
Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;94(1):4-7.
2005: John Routes; Kristin Morris; Misoo C Ellison; Sharon Ryan
Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.
Journal of virology 2005;79(1):116-23.
2004: Anil Nanda; Maeve O'connor; Miriam Anand; Stephen C Dreskin; Lening Zhang; Brittany Hines; Diana Lane; William Wheat; John Routes; Richard Sawyer; Lanny J Rosenwasser; Harold S Nelson
Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract.
The Journal of allergy and clinical immunology 2004;114(6):1339-44.
2004: Christopher A Bates; Misoo C Ellison; David A Lynch; Carlyne D Cool; Kevin K Brown; John Routes
Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.
The Journal of allergy and clinical immunology 2004;114(2):415-21.
2004: Tanya A Miura; Han Li; Kristin Morris; Sharon Ryan; Kristine Hembre; James L Cook; John Routes
Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.
Journal of virology 2004;78(9):4646-54.
2003: Carlyne D Cool; Pradeep R Rai; Michael E Yeager; Daniel Hernandez-Saavedra; Amanda E Serls; Todd M Bull; Mark W Geraci; Kevin K Brown; John Routes; Rubin M Tuder; Norbert F Voelkel
Expression of human herpesvirus 8 in primary pulmonary hypertension.
The New England journal of medicine 2003;349(12):1113-22.
2003: James L Cook; Tanya A Miura; David N Iklé; Andrew M Lewis; John Routes
E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cancer research 2003;63(12):3435-43.
2003: Tanya A Miura; Kristin Morris; Sharon Ryan; James L Cook; John Routes
Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide- and TNF-alpha-dependent mechanisms despite up-regulation of 70-kDa heat shock protein.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(8):4119-26.
2001: John Routes; J C Ryan; S Ryan; Mary C Nakamura
MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection.
International immunology 2001;13(10):1301-7.
2001: James L Cook; John Routes
Role of the innate immune response in determining the tumorigenicity of neoplastic cells.
Developments in biologicals 2001;106():99-107; discussion 107-8, 143-60.
2000: John Routes; LA Colton; Sharon Ryan; Dwight J Klemm
CREB (cAMP response element binding protein) and C/EBPalpha (CCAAT/enhancer binding protein) are required for the superstimulation of phosphoenolpyruvate carboxykinase gene transcription by adenoviral E1a and cAMP.
The Biochemical journal 2000;352 Pt 2():335-42.
2000: John Routes; Sharon Ryan; H Li; J Steinke; James L Cook
Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
Virology 2000;277(1):48-57.
2000: John Routes; Sharon Ryan; A Clase; T Miura; A Kuhl; T A Potter; James L Cook
Adenovirus E1A oncogene expression in tumor cells enhances killing by TNF-related apoptosis-inducing ligand (TRAIL).
Journal of immunology (Baltimore, Md. : 1950) 2000;165(8):4522-7.
2000: John Routes; Harold S Nelson; J A Noda; F T Simon
Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma.
The Journal of allergy and clinical immunology 2000;105(2 Pt 1):391-2.
1999: James L Cook; B A Routes; T A Walker; K L Colvin; John Routes
E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.
Experimental cell research 1999;251(2):414-23.
1999: Greg W Bensch; John Routes
Noninfectious immunologic disorders in adults.
Chest surgery clinics of North America 1999;9(1):113-24, ix.
1996: P A Schkade; John Routes
Hypersensitivity pneumonitis in a patient with hypogammaglobulinemia.
The Journal of allergy and clinical immunology 1996;98(3):710-2.
1996: Dwight J Klemm; L A Colton; S Ryan; John Routes
Adenovirus E1A proteins regulate phosphoenolpyruvate carboxykinase gene transcription through multiple mechanisms.
The Journal of biological chemistry 1996;271(14):8082-8.
1996: John Routes; H Li; S T Bayley; S Ryan; Dwight J Klemm
Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):1055-61.
1995: John Routes; S Ryan
Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells.
Journal of virology 1995;69(12):7639-47.
1995: John Routes; James L Cook
E1A gene expression induces susceptibility to killing by NK cells following immortalization but not adenovirus infection of human cells.
Virology 1995;210(2):421-8.
1994: J Matz; Larry Borish; John Routes; Lanny J Rosenwasser
Oral desensitization to rifampin and ethambutol in mycobacterial disease.
American journal of respiratory and critical care medicine 1994;149(3 Pt 1):815-7.
1993: John Routes; B A Metz; James L Cook
Endogenous expression of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression.
Journal of virology 1993;67(6):3176-81.
1993: B Z Joseph; John Routes; Larry Borish
Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors.
Inflammation 1993;17(3):361-70.
1993: John Routes
Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(10):4315-22.
1992: J Matz; John Routes; Larry Borish
Diffuse pulmonary infiltrates in hypogammaglobulinemia.
Annals of allergy 1992;69(6):485-90.
1992: John Routes
IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(7):2372-7.
1991: John Routes; D Bellgrau; W J McGrory; D S Bautista; F L Graham; James L Cook
Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene.
Journal of virology 1991;65(3):1450-7.
1990: John Routes; James L Cook
Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression. Implications for antiviral immunity.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(7):2763-70.
1989: John Routes; James L Cook
Adenovirus persistence in man. Defective E1A gene product targeting of infected cells for elimination by natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):4022-6.
1987: John Routes; H N Claman
Corticosteroids in inflammatory bowel disease. A review.
Journal of clinical gastroenterology 1987;9(5):529-35.
1976: C McQuarrie; Paul Salvaterra; A De Blas; John Routes; H R Mahler
Studies on nicotinic acetylcholine receptors in mammalian brain. Preliminary characterization of membrane-bound alpha-bungarotoxin receptors in rat cerebral cortex.
The Journal of biological chemistry 1976;251(20):6335-9.